Rare lephants
Screener

Replimune Group, Inc.

REPL ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
10-Q Feb 3, 2026 10-Q
8-K Feb 3, 2026 FORM 8-K
8-K Jan 12, 2026 FORM 8-K
4 Dec 19, 2025 OWNERSHIP DOCUMENT
4 Dec 19, 2025 OWNERSHIP DOCUMENT
4 Dec 19, 2025 OWNERSHIP DOCUMENT
4 Dec 19, 2025 OWNERSHIP DOCUMENT
4 Dec 19, 2025 OWNERSHIP DOCUMENT
4 Dec 11, 2025 OWNERSHIP DOCUMENT
144 Dec 9, 2025
4 Dec 4, 2025 OWNERSHIP DOCUMENT
144 Dec 2, 2025
4 Nov 19, 2025 OWNERSHIP DOCUMENT
4 Nov 19, 2025 OWNERSHIP DOCUMENT
SCHEDULE 13G/A Nov 14, 2025
SCHEDULE 13G/A Nov 14, 2025
SCHEDULE 13G/A Nov 14, 2025
SCHEDULE 13G Nov 14, 2025
S-3/A Nov 6, 2025 S-3/A
8-K Nov 6, 2025 FORM 8-K
10-Q Nov 6, 2025 10-Q
8-K Oct 20, 2025 FORM 8-K
8-K Sep 18, 2025 FORM 8-K
8-K Sep 4, 2025 FORM 8-K
4 Aug 19, 2025 OWNERSHIP DOCUMENT
← Newer Page 4 of 27 · 662 filings Older →